- Investor's Business Daily•6 hours ago
Momenta and Pfizer are unexpectedly giving Teva some breathing room on a generic version of MS drug Copaxone.
- CNBC•7 hours ago
Momenta says Pfizer, a key supplier for its multiple sclerosis drug, has received a warning letter from the Food and Drug Administration.
- Insider Monkey•7 hours ago
Pain Therapeutics, Inc. (NASDAQ:PTIE) put out a fourth-quarter business update, and alongside it, gave us some insight into the possible future of the company’s long suffering abuse deterrent asset, Remoxy. This is one that we have covered in the past on a number of occasions here Market Exclusive, yet one that remains on an as-yet […]
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||33.48 - 33.80|
|52 Week Range||28.74 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||28.66|
|Dividend & Yield||1.28 (3.81%)|
|1y Target Est||N/A|